PMID-sentid	Pub_year	Sent_text		comp_official_name	comp_offsetprotein_name	organism	prot_offset
1822394-11	1991	It appears that the efficacy of all-trans RA is the resultant of multiple parameters (RA concentration, ratio of PML/RAR alpha transcripts to normal RAR alpha, CRABP) which need to be defined to efficiently monitor all-trans RA therapy in APL.	Radium	42-44	cellular retinoic acid binding protein 1	Homo sapiens	160-165	
8207983-9	1994	This induced ATRA hypercatabolytic state should be monitored during consolidation therapy and at relapse by evaluating CRABP and RA metabolite levels, in order to detect ATRA resistance in patients with AML3.	Radium	15-17	cellular retinoic acid binding protein 1	Homo sapiens	119-124	
1316927-5	1992	FPLC analysis also demonstrated a 15-kDa peak of specific RA binding activity, consistent with the presence of cellular retinoic acid binding protein (CRABP).	Radium	58-60	cellular retinoic acid binding protein 1	Homo sapiens	111-149	
1316927-5	1992	FPLC analysis also demonstrated a 15-kDa peak of specific RA binding activity, consistent with the presence of cellular retinoic acid binding protein (CRABP).	Radium	58-60	cellular retinoic acid binding protein 1	Homo sapiens	151-156	
11266607-2	2001	This report describes a novel photoaffinity-based binding assay involving competition between potential ligands of CRABP and [(3)H]atRA or [(3)H]-9-cis-RA for binding to the atRA-binding sites of CRABP I and II.	Radium	116-118	cellular retinoic acid binding protein 1	Homo sapiens	196-210	
7815831-9	1994	This induced ATRA hypercatabolytic state should be monitored during consolidation therapy and at relapse by evaluating CRABP and RA metabolite levels, in order to detect ATRA resistance in patients with AML3.	Radium	15-17	cellular retinoic acid binding protein 1	Homo sapiens	119-124	
1328234-5	1992	Moreover, the level of CRABP-I determines the rate of RA metabolism to 4-oxo-RA such that the higher the CRABP-I level, the faster the metabolism of [3H]retinoic acid.	Radium	24-26	cellular retinoic acid binding protein 1	Homo sapiens	105-112	
2190176-4	1990	In the development of the limb bud, RA has been proposed as a morphogen controlling development via a concentration gradient established by a mechanism thought to involve specific nuclear receptors and a cytosolic binding protein (CRABP).	Radium	36-38	cellular retinoic acid binding protein 1	Homo sapiens	231-236	
6299278-1	1982	Cellular retinoic acid-binding protein (CRABP) was detected in the nuclear fraction of N-methyl-N-nitrosourea-induced mammary cancers after the incubation of cytosol containing [3H]retinoic acid (RA)-bound CRABP with isolated nuclei.	Radium	41-43	cellular retinoic acid binding protein 1	Homo sapiens	0-38	
6299278-1	1982	Cellular retinoic acid-binding protein (CRABP) was detected in the nuclear fraction of N-methyl-N-nitrosourea-induced mammary cancers after the incubation of cytosol containing [3H]retinoic acid (RA)-bound CRABP with isolated nuclei.	Radium	41-43	cellular retinoic acid binding protein 1	Homo sapiens	206-211	
6299278-3	1982	[3H]RA-CRABP was found to be a prerequisite for the detection of nuclear binding, since the incubation of isolated nuclei or 0.4 M-KCl extract of the nuclei with [3H]RA did not result in any significant binding.	Radium	4-6	cellular retinoic acid binding protein 1	Homo sapiens	7-12